ABINGDON, England, Nov. 8, 2019 /PRNewswire/ — OBN (UK) Ltd., the membership organisation that supports the life sciences industry, is delighted to announce the winners of the 2019 OBN Awards.
The Awards, which are in their 11th year, celebrate the best of UK life sciences – from outstanding scientific innovation within Biotech, Medtech and Digital Health, to the companies that support the industry and the fundraisers that make it happen. This year’s event hosted an audience of over 250 life sciences industry leaders at the Oxford Examination Schools.
John Harris, CEO of OBN, said: “We received an incredible number of entries yet again this year, so competition has been really tough for all nominees. All our winners and finalists are truly innovative, at the very top of their respective sectors, and set a great example to the rest of the industry. We have introduced several new categories this year to reflect industry trends. The turn-out and support we have received is a true reflection of how buoyant our industry continues to be, and I would like to thank all our sponsors and supporters for helping us make the OBN Awards once again such a great success.”
The winners of the awards are:
Best Start-up Biotech Company, kindly sponsored by James Cowper-Kreston
Winner – Grey Wolf Therapeutics
Develop next generation immunotherapies that illuminate non-responsive tumours for destruction by the immune system.
Best Start-up Medtech Company
Winner – Caristo Diagnostics
Develop a novel technology that can identify regions of inflammation around coronary arteries and which has the potential to transform the diagnostic power of routine coronary CT angiograms.
Most Transformative Digital Healthcare Company
Winner – Sensyne Health
Combine clinical artificial intelligence technology and ethically sourced, anonymised patient data to help provide better healthcare.
Winner – RSSL
Help world leading brands and SME’s develop and supply products that are safe, innovative and of the highest quality.
Best Specialist CRO, kindly sponsored by ThermoFisher Scientific
Provide personalised oncology and rare disease clinical operations with an emphasis on the application of biomarkers to drive improvements in clinical endpoints.
Best Emerging Medtech Company, kindly sponsored by BDO
Winner – Open Bionics
Build and develop the next generation of bionic limbs, turning disabilities into ‘superpowers’, starting with the Hero Arm.
Best Emerging Biotech Company, kindly sponsored by Precision For Medicine, Oncology and Rare Disease
Winner – NodThera
Developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of chronic inflammatory diseases.
Best Sector Support Organisation
Winner – UKI2S
The UK Innovation and Science Seed Fund, build and grow technology companies stemming from the UK’s diverse research base.
Most Innovative Big Pharma Organisation, kindly sponsored by Milton Park
Winner – Johnson & Johnson Innovation
Has demonstrated some excellent collaborations, providing a wide range of platforms to support their internal and external pipeline of technologies which is positively impacting patient lives.
The BioSeed® ‘One to Watch’ Award, kindly sponsored by Mills & Reeve
Winner – Attomarker
Develop iPhone connected diagnostic technology to enable rapid and personal access to diagnostic tests conventionally carried out in analytical laboratories.
Best Established Biotech Company, kindly sponsored by World Courier
Winner – Bicycle Therapeutics
Exploit their proprietary phage display technology to select peptide-like ‘Bicycles’ for development into novel therapeutics.
Best Established Medtech Company
Winner – Endomag
Help tens of thousands of women across the world to access more accurate and less invasive breast cancer care.
Special Recognition Award
Winner – Sunil Shah, o2h for his rare vision and supportive ethos to the companies he invests in: offering support beyond cash alone, but also invaluable experience, contacts and personal time. He has an inspiring passion and enthusiasm for science and business.
About the OBN Awards – www.obn-awards.com
The OBN Awards, now in its 11th year, celebrates innovation and achievement across the UK Life Sciences Industry. We are proud that the awards remain independent with categories that cover Biotech, Medtech, and Digital Health and recognises achievements from emerging R&D companies to large pharma and life sciences investors.
OBN Awards 2018 Independent Judging Panel
Michel de Baar – Executive Director, BD&L Europe – MSD
Jon Bircher – Chief Commercial Officer – Cello Health
David Browning – CEO – Fixed-Phage
John Chaddock – VP Interim Head Neuroscience Therapeutic Area, Site Head – Ipsen Bioinnovation
Sue Charles – Managing Partner – Instinctif Partners
Bill Fleming – CFO – Ultromics
Peter Hamley – CSO – Samsara Therapeutics
John Harris – CEO – OBN
Jutta Heix – International Advisor – Oslo Cancer Cluster
Sarah Holland – VP Global Head of Licensing – Lonza
Ian Oliver – Partner – BDO
Carlos Pittol – Director – Clubb Capital
Jonathan Rohll – Head of Business Information – OBN
Clare Sarvary-Fourrier – SVP Clincal Operations – Europe – Precision for Medicine, Oncology & Rare Disease
Jason Slingsby – Head of Business Development – Oxford Biomedica
Robert Tansley – Investment Director – Cambridge Innovation Capital
Rebecca Todd – Investment Director – Longwall Venture Partners
OBN is the Membership organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. Our 400+ member companies are located throughout the UK and benefit from our networking, partnering, purchasing, advising and advocacy activities.
OBN delivers four World-Quality flagships events per annum:
BioTrinity is Europe’s leading Biopartnering and Investment conference, in London on 28 – 29 April 2020 (its 14th year).
BioSeed is a unique platform for early-stage life sciences companies, TTO’s, and Universities throughout Europe seeking equity investment from angels, HNW individuals, specialist crowd-funders, and PE / VC / Pharma funders genuinely interested in seed and Series A funding (London, 20 January 2020).
BioForward is a high-quality international partnering conference providing a roadmap for R&D companies looking to achieve sustainable business growth.
This is the UK’s leading life sciences awards event, celebrating innovation & outstanding achievement across the UK Life Sciences Industry.
Further information about OBN’s tailored networking and partnering events, purchasing consortium, advice, consultancy services and advocacy activities is available on OBN’s website www.obn.org.uk
Head of Events, OBN
Communications & Marketing Co-ordinator, OBN
Citigate Dewe Rogerson